Cytokinetics, Incorporated · NASDAQ:CYTK
Kaye Edward M. MD sold 2,933 Cytokinetics, Incorporated shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 1, 2026
On Jun 1, 2026, Kaye Edward M. MD (Director) sold 2,933 Cytokinetics, Incorporated shares at US$76.09 for US$223K under a trading plan, leaving 10,283 shares. Filed Jun 1, 2026 (Form 4).
- Sold
- 2,933 shares
- Price
- US$76.09
- Value
- US$223K
- Holding after
- 10,283 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 2,933 | US$76.09 | 10,283 | Direct |
Source
Related
- Cytokinetics, Incorporated
- Kaye Edward M. MD
- Cytokinetics, Incorporated shareholders
- Form 4 · Kaye Edward M. MD · Oct 20, 2026
- Form 4 · Kaye Edward M. MD · Jul 16, 2026
- Form 4 · Kaye Edward M. MD · May 27, 2026
- Form 4 · Kaye Edward M. MD · Apr 15, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026